VERAXA Biotech (NASDAQ: VRXA) provided a corporate and pipeline update highlighting progress during the first half of 2026, ...

As Greater Boston’s biotech industry sheds jobs, three unlikely regions are showing promise as up-and-coming hubs.

Texas Biomed is offering its research labs to an international biotech company looking to develop new technologies against screwworm.

VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...

The industry contributes $50 billion to the state GDP, and employs 130,000 people across research and manufacturing.

This cell-like structure can grow, feed, divide and compete. Researchers ponder what it means for the future of synthetic ...

The work with Nvidia also focuses on the agentic guardrails required for the responsible and reliable deployment of AI in lab ...

A slew of start-ups and academic labs are leaning on AI agents and bots, rather than humans, to speed up their chemistry ...

VERAXA Biotech (NASDAQ: VRXA) an emerging developer of novel cancer therapies, announced it has expanded its laboratory ...

Antares Therapeutics, a Scorpion spinout with labs in South San Francisco and Boston, has inked a collaboration with Swiss ...

There are only about 300 professional cryobiologists in the world. Four of them were recently hired to work in this new Bothell research facility.

Venture funding and steady openings are pushing Peninsula biotech to hire — and some displaced tech workers may land in labs.